The pathogenesis of pulmonary fibrosis: a moving target

Wim A Wuyts1, Carlo Agostini, Katerina M Antoniou

  • 1Laboratory of Pneumology, Dept of Respiratory Medicine, Katholieke Universiteit Leuven, Leuven, Belgium. wim.wuyts@uzleuven.be

Insights

Pulmonary fibrosis, a fatal lung disease, involves excessive matrix buildup. This review explores initiating factors and pathways, aiming to guide research toward effective combination antifibrotic therapies.

Area of Science:

  • Pulmonary medicine
  • Pathology
  • Cell biology

Background:

  • Pulmonary fibrosis represents the end-stage of various diffuse parenchymal lung diseases.
  • It is characterized by aberrant matrix deposition, leading to irreversible lung architecture destruction and mortality.
  • Despite advances, the primary pathogenic pathways remain incompletely understood.

Purpose of the Study:

  • To review current knowledge on pulmonary fibrosis pathogenesis.
  • To discuss initiating factors, including viral infections and gastro-oesophageal reflux.
  • To explore ancillary pathways such as immune responses, stress pathways, coagulation, and stem cell involvement.

Main Methods:

  • This is a review article, synthesizing existing scientific literature.
  • It integrates clinical observations with mechanistic insights.
  • Focuses on identifying key pathways in fibrogenesis.

Main Results:

  • Susceptibility and injurious agents are proposed as initiating factors.
  • Immune mechanisms, oxidative stress, endoplasmic reticulum stress, coagulation, and stem cells are discussed as ancillary pathways.
  • An integrated view of fibrogenesis is presented.

Conclusions:

  • Understanding the complex interplay of initiating and ancillary pathways is crucial for advancing pulmonary fibrosis research.
  • Developing effective antifibrotic strategies will likely require targeting multiple key pathways simultaneously.
  • A comprehensive "big picture" overview is essential for guiding future therapeutic development.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...